New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- ATR Biotech
- P.O. Box 460
- Laurel MD, 20725
- UNITED STATES
ATR has a long history as a customer-focused market-driven company that responds quickly to changes in the biomedical research field.
Our products combine the best technical innovations, attention to detail and commitment to quality. We can customize our products to fit almost any need.